top of page

Allergen receives positive opinion for IBS drug

Allergan plc today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Truberzi (eluxadoline) in the European Union. Trubberzi is an oral medication taken to relieve the main symptoms of irritable bowel syndrome with diarrhoea (IBS-D) in adults.

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page